Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer

International Journal of Oncology

Volumn 39, Issue 3, 2011, Pages 727-733

  Tada, Yasuhiro ^a   Yokomizo, Akira ^a   Shiota, Masaki ^a   Tsunoda, Toshiyuki ^a   Plass, Christoph ^b,c   Naito, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Bladder cancer; Cisplatin; DNA methylation; TLX3

Indexed keywords

CISPLATIN; HOMEODOMAIN PROTEIN; PROTEIN TLX3; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA METHYLATION; DRUG RESISTANCE; DRUG SENSITIVITY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; T CELL LEUKEMIA; TLX3 GENE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; GENES, HOMEOBOX; HOMEODOMAIN PROTEINS; HUMANS; TRANSFECTION; URINARY BLADDER NEOPLASMS;

EID: 79959970381     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1049     Document Type: Article

References (29)

1. Lawrence HJ and Largman C: Homeobox genes in normal hematopoiesis and leukemia. Blood 80: 2445-2453, 1992.
2. Owens BM and Hawley RG: HOX and non-HOX homeobox genes in leukemic hematopoiesis. Stem Cells 20: 364-379, 2002.
3. Wang Y, Hayakawa J, Long F, et al: 'Promoter array' studies identify cohorts of genes directly regulated by methylation, copy number change, or transcription factor binding in human cancer cells. Ann NY Acad Sci 1058: 162-185, 2005.
4. Tada Y, Wada M, Taguchi K, et al: The association of death-associated protein kinase hypermethylation with early recurrence in superficial bladder cancers. Cancer Res 62: 4048-4053, 2002.
5. Tada Y, Wada M, Migita T, et al: Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin. Int J Cancer 98: 630-635, 2002.
6. Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA and Plass C: Epigenetic modulation of tumor suppressor CCAAT/ enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst 98: 396-406, 2006.
7. Shen Y, Chow J, Wang Z and Fan G: Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Hum Mol Genet 15: 2623-2635, 2006.
8. Vucic EA, Brown CJ and Lam WL: Epigenetics of cancer progression. Pharmacogenomics 9: 215-234, 2008.
9. Li LC, Carroll PR and Dahiya R: Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst 97: 103-115, 2005.
10. Kalebic T: Epigenetic transitions: towards therapeutic targets. Expert Opin Ther Targets 7: 693-699, 2003.
11. Kim WJ and Kim YJ: Epigenetic biomarkers in urothelial bladder cancer. Expert Rev Mol Diagn 9: 259-269, 2009.
12. Nishiyama N, Arai E, Chihara Y, et al: Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage. Cancer Sci 101: 231-240, 2010.
13. Wang SS, Smiraglia DJ, Wu YZ, et al: Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res 68: 2489-2497, 2008.
14. Smiraglia DJ, Smith LT, Lang JC, et al: Differential targets of CpG island hypermethylation in primary and metastatic head and neck squamous cell carcinoma (HNSCC). J Med Genet 40: 25-33, 2003.
15. Park J, Brena RM, Gruidl M, et al: CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis. Cancer Biomark 1: 193-200, 2005.
16. Kotoh S, Naito S, Yokomizo A, Kohno K, Kuwano M and Kumazawa J: Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype. J Urol 157: 1054-1058, 1997.
17. Kotoh S, Naito S, Yokomizo A, et al: Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. Cancer Res 54: 3248-3252, 1994.
18. Dai Z, Lakshmanan RR, Zhu WG, et al: Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia 3: 314-323, 2001.
19. Smiraglia DJ, Fruhwald MC, Costello JF, et al: A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels. Genomics 58: 254-262, 1999.
20. Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
21. Nagel S, Kaufmann M, Drexler HG and MacLeod RA: The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14) (q35.1;q32.2). Cancer Res 63: 5329-5334, 2003.
22. Shiota M, Yokomizo A, Kashiwagi E, et al: Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin. Cancer Sci 101: 1177-1185, 2010.
23. Shiota M, Yokomizo A, Tada Y, et al: P300/CBP-associated factor regulates Y-box binding protein-1 and promotes cancer cell growth, cancer invasion and drug resistance. Cancer Sci 101: 1797-1806, 2010.
24. Maehara Y, Anai H, Kusumoto H and Sugimachi K: Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma. Eur J Surg Oncol 13: 203-206, 1987.
25. Su X, Drabkin H, Clappier E, et al: Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3. Genes Chromosomes Cancer 45: 846-855, 2006.
26. Shi Y, Chichung Lie D, Taupin P, et al: Expression and function of orphan nuclear receptor TLX in adult neural stem cells. Nature 427: 78-83, 2004.
27. Nagel S, Venturini L, Przybylski GK, et al: Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk Lymphoma 50: 101-108, 2009.
28. Kohno K, Uchiumi T, Niina I, et al: Transcription factors and drug resistance. Eur J Cancer 41: 2577-2586, 2005.
29. Hinata N, Shirakawa T, Zhang Z, et al: Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type-p53 but not in p53-mutated bladder cancer cells. Urol Res 31: 387-396, 2003.